EMMA, MARIA RITA
EMMA, MARIA RITA
Istituto per la Ricerca e l'Innovazione Biomedica -IRIB
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
2022 Abrams, Sl; Duda, P; Akula, Sm; Steelman, Ls; Follo, Ml; Cocco, L; Ratti, S; Martelli, Am; Montalto, G; Emma, Mr; Cervello, M; Rakus, D; Gizak, A; Mccubrey, Ja
Hepatocellular Carcinoma: A Difficult Cancer to Treat
2021 Cusimano, Antonella; Soresi, Maurizio; Montalto, Giuseppe; Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Cervello, Melchiorre; Giannitrapani, Lydia
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies
2021 Emma, Mr; Augello, G; Di Stefano, V; Azzolina, A; Giannitrapani, L; Montalto, G; Cervello, M; Cusimano, A
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma
2021 Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Puleio, Roberto; Condorelli, Lucia; Cusimano, Antonella; Giannitrapani, Lydia; A McCubrey, James; Lucio Iovanna, Juan; Cervello, Melchiorre
GDF11 induces mild hepatic fibrosis independent of metabolic health
2020 Frohlich, J; Kovacovicova, K; Mazza, T; Emma, Mr; Cabibi, D; Foti, M; Sobolewski, C; Oben, Ja; Peyrou, M; Villarroya, F; Soresi, M; Rezzani, R; Cervello, M; Bonomini, F; Alisi, A; Vinciguerra, M
GSK-3 in liver diseases: Friend or foe?
2020 Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
2020 Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L;
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
2020 Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma
2019 Akula, Sm; Abrams, Sl; Steelman, Ls; Emma, Mr; Augello, G; Cusimano, A; Azzolina, A; Montalto, G; Cervello, M; Mccubrey, Ja
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors
2019 Tesauro, D; Mastro, R; Cusimano, A; Emma, Mr; Cervello, M
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
2019 Augello, G; Emma, Mr; Cusimano, A; Azzolina, A; Mongiovi, S; Puleio, R; Cassata, G; Gulino, A; Belmonte, B; Gramignoli, R; Strom, Sc; Mccubrey, Ja; Montalto, G; Cervello, M
Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample
2018 Augello, Giuseppa; Balasus, Daniele; Fusilli, Caterina; Mazza, Tommaso; Emma, MARIA RITA; Giannitrapani, Lydia; Agliastro, Rosalia; Cervello, Melchiorre; Montalto, Giuseppe
Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference
2018 Chiara Botto; Giuseppa Augello; Erika Amore; Maria Rita Emma; Antonina Azzolina; Gennara Cavallaro; Melchiorre Cervello; Maria Luisa BondìChiara Botto; Giuseppa Augello; Erika Amore; Maria Rita Emma; Antonina Azzolina; Gennara Cavallaro; Melchiorre Cervello; Maria Luisa Bondì
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
2018 Augello, Giuseppa; Modica, Martina; Azzolina, Antonina; Puleio, Roberto; Cassata, Giovanni; Emma, MARIA RITA; DI SANO, Caterina; Cusimano, Antonella; Montalto, Giuseppe; Cervello, Melchiorre
Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment
2017 Luisa Bondì, Maria; Emma, MARIA RITA; Botto, Chiara; Augello, Giuseppa; Azzolina, Antonina; Di Gaudio, Francesca; Fabiola Craparo, Emanuela; Cavallaro, Gennara; Bachvarov, Dimcho; Cervello, Melchiorre
In vitro and in vivo antitumor activity of the proteasome inhibitor MLN2238 in hepatocellular carcinoma cells
2016 Augello, Giuseppa; Emma, MARIA RITA; Modica, Martina; DI SANO, Caterina; Puleio, Roberto; Azzolina, Antonina; Cusimano, Antonella; Montalto Melchiorre Cervello, Giuseppe
Lipid nanocarriers containing sorafenib inhibit colonies formation into human hepatocarcinoma cells
2015 M.L. Bondì; C. Botto; E. Amore; M.R. Emma; G. Augello; E.F. Craparo; M. Cervello
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53 | 1-gen-2022 | Abrams, Sl; Duda, P; Akula, Sm; Steelman, Ls; Follo, Ml; Cocco, L; Ratti, S; Martelli, Am; Montalto, G; Emma, Mr; Cervello, M; Rakus, D; Gizak, A; Mccubrey, Ja | |
Hepatocellular Carcinoma: A Difficult Cancer to Treat | 1-gen-2021 | Cusimano, Antonella; Soresi, Maurizio; Montalto, Giuseppe; Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Cervello, Melchiorre; Giannitrapani, Lydia | |
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies | 1-gen-2021 | Emma, Mr; Augello, G; Di Stefano, V; Azzolina, A; Giannitrapani, L; Montalto, G; Cervello, M; Cusimano, A | |
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma | 1-gen-2021 | Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Puleio, Roberto; Condorelli, Lucia; Cusimano, Antonella; Giannitrapani, Lydia; A McCubrey, James; Lucio Iovanna, Juan; Cervello, Melchiorre | |
GDF11 induces mild hepatic fibrosis independent of metabolic health | 1-gen-2020 | Frohlich, J; Kovacovicova, K; Mazza, T; Emma, Mr; Cabibi, D; Foti, M; Sobolewski, C; Oben, Ja; Peyrou, M; Villarroya, F; Soresi, M; Rezzani, R; Cervello, M; Bonomini, F; Alisi, A; Vinciguerra, M | |
GSK-3 in liver diseases: Friend or foe? | 1-gen-2020 | Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M; | |
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods | 1-gen-2020 | Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L; | |
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment | 1-gen-2020 | Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M; | |
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma | 1-gen-2019 | Akula, Sm; Abrams, Sl; Steelman, Ls; Emma, Mr; Augello, G; Cusimano, A; Azzolina, A; Montalto, G; Cervello, M; Mccubrey, Ja | |
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors | 1-gen-2019 | Tesauro, D; Mastro, R; Cusimano, A; Emma, Mr; Cervello, M | |
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma | 1-gen-2019 | Augello, G; Emma, Mr; Cusimano, A; Azzolina, A; Mongiovi, S; Puleio, R; Cassata, G; Gulino, A; Belmonte, B; Gramignoli, R; Strom, Sc; Mccubrey, Ja; Montalto, G; Cervello, M | |
Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample | 1-gen-2018 | Augello, Giuseppa; Balasus, Daniele; Fusilli, Caterina; Mazza, Tommaso; Emma, MARIA RITA; Giannitrapani, Lydia; Agliastro, Rosalia; Cervello, Melchiorre; Montalto, Giuseppe | |
Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference | 1-gen-2018 | Chiara Botto; Giuseppa Augello; Erika Amore; Maria Rita Emma; Antonina Azzolina; Gennara Cavallaro; Melchiorre Cervello; Maria Luisa BondìChiara Botto; Giuseppa Augello; Erika Amore; Maria Rita Emma; Antonina Azzolina; Gennara Cavallaro; Melchiorre Cervello; Maria Luisa Bondì | |
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells | 1-gen-2018 | Augello, Giuseppa; Modica, Martina; Azzolina, Antonina; Puleio, Roberto; Cassata, Giovanni; Emma, MARIA RITA; DI SANO, Caterina; Cusimano, Antonella; Montalto, Giuseppe; Cervello, Melchiorre | |
Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment | 1-gen-2017 | Luisa Bondì, Maria; Emma, MARIA RITA; Botto, Chiara; Augello, Giuseppa; Azzolina, Antonina; Di Gaudio, Francesca; Fabiola Craparo, Emanuela; Cavallaro, Gennara; Bachvarov, Dimcho; Cervello, Melchiorre | |
In vitro and in vivo antitumor activity of the proteasome inhibitor MLN2238 in hepatocellular carcinoma cells | 1-gen-2016 | Augello, Giuseppa; Emma, MARIA RITA; Modica, Martina; DI SANO, Caterina; Puleio, Roberto; Azzolina, Antonina; Cusimano, Antonella; Montalto Melchiorre Cervello, Giuseppe | |
Lipid nanocarriers containing sorafenib inhibit colonies formation into human hepatocarcinoma cells | 1-gen-2015 | M.L. Bondì; C. Botto; E. Amore; M.R. Emma; G. Augello; E.F. Craparo; M. Cervello |